Patrick Burnett
See Remarks at Arcutis Biotherapeutics, Inc. (ARQT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 21SEC | ARQTArcutis Biotherapeutics, Inc. | Sell | 1,697117,592 held (−1%) | $27.00 | $46K | -1.6% |
| Aug 13SEC | ARQTArcutis Biotherapeutics, Inc. | Sell | 8,300119,289 held (−7%) | $26.52 | $220K | +0.2% |
| Aug 13SEC | ARQTArcutis Biotherapeutics, Inc. | Sell | 6,700119,289 held (−5%) | $26.08 | $175K | +1.9% |
| Aug 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 955119,289 held (−1%) | $26.12 | $25K | +1.8% |
| May 13SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 222120,244 held (−0%) | $21.05 | $5K | +26.3% |
| May 6SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 684120,466 held (−1%) | $23.61 | $16K | +12.6% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 6,106121,295 held (−5%) | $25.16 | $154K | +5.6% |
| Mar 3SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 181121,150 held (−0%) | $25.91 | $5K | +2.6% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 3,67590,445 held (−4%) | $25.50 | $94K | +4.2% |
| Feb 4SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 9,79480,651 held (−11%) | $25.81 | $253K | +3.0% |
| Jan 7SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 2,49094,120 held (−3%) | $28.98 | $72K | -8.3% |
| Jan 2SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 54197,766 held (−1%) | $28.81 | $16K | -7.7% |
| Jan 2SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 1,15696,610 held (−1%) | $29.39 | $34K | -9.6% |
| Dec 17SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 11,50098,307 held (−10%) | $28.94 | $333K | -8.2% |
| Nov 10SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 17,25098,325 held (−15%) | $24.18 | $417K | +9.9% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 2,607102,204 held (−2%) | $24.71 | $64K | +7.6% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 15102,189 held (−0%) | $25.40 | $381 | +4.6% |
| Nov 5SEC | ARQTArcutis Biotherapeutics, Inc. | Sell Plan | 3,86498,325 held (−4%) | $23.72 | $92K | +12.1% |
- Sell
See Remarks Patrick Burnett sold $25K of ARQT at $26.12 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Patrick Burnett sold $5K of ARQT at $21.05 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Patrick Burnett sold $16K of ARQT at $23.61 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Patrick Burnett sold $154K of ARQT at $25.16 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Patrick Burnett sold $5K of ARQT at $25.91 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks Patrick Burnett sold $94K of ARQT at $25.50 — pre-scheduled 10b5-1 plan sale.